Publications by authors named "Ralf Gutzmer"

100Publications

Histamine 2 Receptor Agonism and Histamine 4 Receptor Antagonism Ameliorate Inflammation in a Model of Psoriasis.

Acta Derm Venereol 2020 Oct 26. Epub 2020 Oct 26.

Institute for Pharmacology, Toxicology and Pharmacy, University of Veterinary Medicine Hannover, Hannover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2340/00015555-3674DOI Listing
October 2020

Successful treatment of a metastatic melanoma with Talimogen laherparepvec (T-VEC) in a liver transplant patient.

J Dtsch Dermatol Ges 2020 Sep 28. Epub 2020 Sep 28.

Klinik für Dermatologie, Allergologie und Venerologie, Hauttumorzentrum Hannover (HTZH), Medizinische Hochschule Hannover.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ddg.14284DOI Listing
September 2020

The H R is highly expressed on eosinophils from AD patients and IL-4 upregulates expression and function via the JAK/STAT pathway.

Allergy 2020 Sep 25. Epub 2020 Sep 25.

Division of Immunodermatology and Allergy Research, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/all.14599DOI Listing
September 2020

Expression of Glioma-associated oncogene homolog 1 as biomarker with sonidegib in advanced basal cell carcinoma.

Oncotarget 2020 Sep 15;11(37):3473-3483. Epub 2020 Sep 15.

Manchester Academic Health Science Centre, Manchester University and Salford Royal NHS Trust, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.27735DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500103PMC
September 2020

Programmed cell death protein 1 inhibitors in advanced cutaneous squamous cell carcinoma: real-world data of a retrospective, multicenter study.

Eur J Cancer 2020 Oct 31;138:125-132. Epub 2020 Aug 31.

Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2020.07.029DOI Listing
October 2020

Histamine down-regulates the FCERI α-chain expression in human IL-4-activated M2 macrophages.

Allergy 2020 Sep 3. Epub 2020 Sep 3.

Division of Immunodermatology and Allergy Research, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/all.14576DOI Listing
September 2020

Melanoma brain metastases - Interdisciplinary management recommendations 2020.

Cancer Treat Rev 2020 Sep 18;89:102083. Epub 2020 Jul 18.

Skin Cancer Center at the University Cancer Centre and National Center for Tumor Diseases, Department of Dermatology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2020.102083DOI Listing
September 2020

Nebenwirkungsmanagement bei Immun-Checkpoint-Blockade durch CTLA-4- und PD-1-Antikörper beim metastasierten Melanom - ein Update.

J Dtsch Dermatol Ges 2020 Jun;18(6):582-609

Klinik für Dermatologie, Allergologie und Venerologie, Hauttumorzentrum Hannover, Medizinische Hochschule Hannover.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ddg.14128_gDOI Listing
June 2020

Side effect management during immune checkpoint blockade using CTLA-4 and PD-1 antibodies for metastatic melanoma - an update.

J Dtsch Dermatol Ges 2020 Jun 3;18(6):582-609. Epub 2020 Jun 3.

Department of Dermatology, Venereology and Allergology, Skin Cancer Center, Hanover Medical School, Hanover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ddg.14128DOI Listing
June 2020

Actinic Keratosis and Cutaneous Squamous Cell Carcinoma.

Dtsch Arztebl Int 2019 09;116(37):616-626

Skin Cancer Center Hannover, Department of Dermatology, Hannover Medical School; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Leipzig; Department of Radiotherapy, University Hospital Regensburg; Department of Oromaxillofacial, Plastic and Esthetic Surgery, Osnabrück Hospital GmbH, Osnabrück; Department of Dermatology and Allergology, University Hospital (LMU), Munich.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3238/arztebl.2019.0616DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819699PMC
September 2019

Melanoma-specific survival in patients with positive sentinel lymph nodes: Relevance of sentinel tumor burden.

Eur J Cancer 2019 12 31;123:83-91. Epub 2019 Oct 31.

Skin Cancer Center Hannover, Department of Dermatology and Allergy, Hannover Medical School, Carl Neuberg Strasse 1, D-30625 Hannover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2019.07.004DOI Listing
December 2019

Neues zum kutanen Plattenepithelkarzinom.

J Dtsch Dermatol Ges 2019 Oct;17(10):1097-1098

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ddg.13949_gDOI Listing
October 2019

Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanoma.

Eur J Cancer 2019 09 8;119:18-29. Epub 2019 Aug 8.

Department of Dermatology, University Hospital Essen, Essen, Germany and German Cancer Consortium of Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2019.06.011DOI Listing
September 2019

Histamine up-regulates oncostatin M expression in human M1 macrophages.

Br J Pharmacol 2020 02 11;177(3):600-613. Epub 2019 Dec 11.

Division of Immunodermatology and Allergy Research, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bph.14796DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012943PMC
February 2020

Hedgehog Pathway Inhibition for the Treatment of Basal Cell Carcinoma.

Target Oncol 2019 06;14(3):253-267

Ameriderm Research, Ormond Beach, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-019-00648-2DOI Listing
June 2019

Combination of denosumab and immune checkpoint inhibition: experience in 29 patients with metastatic melanoma and bone metastases.

Cancer Immunol Immunother 2019 Jul 11;68(7):1187-1194. Epub 2019 Jun 11.

Department of Dermatology and Allergy, Skin Cancer Center Hannover, Medizinische Hochschule Hannover, Carl Neuberg Str. 1, 30625, Hannover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-019-02353-5DOI Listing
July 2019

Hedgehog signaling inhibitors in solid and hematological cancers.

Cancer Treat Rev 2019 Jun 6;76:41-50. Epub 2019 May 6.

Ameriderm Research, 725 W Granada Blvd Ste 44, Ormond Beach, FL 32174, USA; University of Central Florida, Orlando, FL, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2019.04.005DOI Listing
June 2019

Risk Factors for Developing Nonmelanoma Skin Cancer after Lung Transplantation.

J Skin Cancer 2019 10;2019:7089482. Epub 2019 Mar 10.

Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2019/7089482DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431522PMC
March 2019

Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases.

Eur J Cancer 2019 03 7;110:11-20. Epub 2019 Feb 7.

Skin Cancer Center at the University Cancer Centre, Department of Dermatology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; National Center for Tumor Diseases (NCT), Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2018.12.023DOI Listing
March 2019

Practical clinical guide on the use of talimogene laherparepvec monotherapy in patients with unresectable melanoma in Europe.

Eur J Dermatol 2018 Dec;28(6):736-749

Skin Cancer Centre/Dermatology Clinic, Universitätsspital Zürich, Zürich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/ejd.2018.3447DOI Listing
December 2018

Stimulation of histamine H receptors increases the production of IL-9 in Th9 polarized cells.

Br J Pharmacol 2020 02 21;177(3):614-622. Epub 2019 Feb 21.

Division of Immunodermatology and Allergy Research, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bph.14566DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012944PMC
February 2020

The role of the histamine H receptor in atopic dermatitis and psoriasis.

Br J Pharmacol 2020 02 2;177(3):490-502. Epub 2019 Jan 2.

Division of Immunodermatology and Allergy Research, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bph.14550DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012951PMC
February 2020

Melanoma.

Lancet 2018 09;392(10151):971-984

Department of Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium, Heidelberg, Germany.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01406736183155
Publisher Site
http://dx.doi.org/10.1016/S0140-6736(18)31559-9DOI Listing
September 2018

The mTOR-inhibitor Sirolimus decreases the cyclosporine-induced expression of the oncogene ATF3 in human keratinocytes.

J Dermatol Sci 2018 Nov 5;92(2):172-180. Epub 2018 Sep 5.

Skin Cancer Center Hannover, Department for Dermatology and Allergy, Hannover Medical School, Carl-Neuberg-Straße 1, 30625 Hannover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jdermsci.2018.08.013DOI Listing
November 2018

The Anaphylatoxin C3a Receptor Expression on Human M2 Macrophages Is Down-Regulated by Stimulating the Histamine H4 Receptor and the IL-4 Receptor.

J Innate Immun 2018 20;10(4):349-362. Epub 2018 Jul 20.

Division of Immunodermatology and Allergy Research, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000490426DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757164PMC
October 2019

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma.

N Engl J Med 2018 May 15;378(19):1789-1801. Epub 2018 Apr 15.

From the Gustave Roussy Cancer Campus Grand Paris and University Paris-Saclay, Villejuif (A.M.M.E., C.R.), Hospices Civils de Lyon Cancer Institute, Cancer Research Center of Lyon, Lyon University, Lyon (S.D.), and Aix-Marseille University, Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, Marseille (J.-J.G.) - all in France; Netherlands Cancer Institute-Antoni van Leeuwenhoek (C.U.B., A.C.J.A.) and VU University Medical Center (A.J.M.E.), Amsterdam, and Radboud University Medical Center Nijmegen, Nijmegen (R.K.) - all in the Netherlands; Azienda Ospedaliera Papa Giovanni XXIII, Bergamo (M. Mandala), Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico Fondazione G. Pascale, Naples (P.A.A.), and Universita Degli Studi Di Siena-Policlinico le Scotte, Siena (M. Maio) - all in Italy; Melanoma Institute Australia, the University of Sydney, and Mater and Royal North Shore Hospitals (G.V.L.) and Westmead and Blacktown Hospitals, Melanoma Institute Australia and the University of Sydney (M.S.C.), Sydney, Princess Alexandra Hospital, University of Queensland, Brisbane (V.A.), Alfred Hospital (A.H.) and Peter MacCallum Cancer Centre (S. Sandhu), Melbourne, VIC, and Fiona Stanley Hospital-University of Western Australia-Edith Cowan University Perth, Perth (A.K.) - all in Australia; Cancer Research Center, Moscow (M.L.); Royal Marsden Hospital, London (J.L.); Hospital Clinic Universitari de Barcelona, Barcelona (S.P.); Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland (P.R.); University Hospital Essen, Essen and German Cancer Consortium, Heidelberg (D.S.), and the Skin Cancer Center, Department of Dermatology, Hannover Medical School, Hannover (R.G.) - all in Germany; Washington University School of Medicine, St. Louis (L.H.-A.); Centre Hospitalier de l'Université de Montréal (CHUM), Centre de Recherche du CHUM, Montreal (R.J.); Christie NHS Foundation Trust, Manchester, United Kingdom (P.L.); Merck, Kenilworth, NJ (N.I.); and the European Organization for the Research and Treatment of Cancer Headquarters, Brussels (S.M., S. Suciu).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1802357DOI Listing
May 2018

The histamine H4 receptor modulates the differentiation process of human monocyte-derived M1 macrophages and the release of CCL4/MIP-1β from fully differentiated M1 macrophages.

Inflamm Res 2018 Jun 29;67(6):503-513. Epub 2018 Mar 29.

Division of Immunodermatology and Allergy Research, Department of Dermatology and Allergy, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00011-018-1140-0DOI Listing
June 2018

Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders.

Cancer Immunol Immunother 2018 05 27;67(5):825-834. Epub 2018 Feb 27.

Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hanover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-018-2134-zDOI Listing
May 2018

Treatment-related hemophagocytic lymphohistiocytosis secondary to checkpoint inhibition with nivolumab plus ipilimumab.

Eur J Cancer 2018 04 19;93:150-153. Epub 2018 Feb 19.

Skin Cancer Center Hannover, Department of Dermatology and Allergy, Hannover Medical School, Carl Neuberg Str. 1, 30625 Hannover, Germany. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09598049183007
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2018.01.063DOI Listing
April 2018

Progression patterns under BRAF inhibitor treatment and treatment beyond progression in patients with metastatic melanoma.

Cancer Med 2018 01 20;7(1):95-104. Epub 2017 Dec 20.

Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.1267DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773979PMC
January 2018

PD-L1 status does not predict the outcome of BRAF inhibitor therapy in metastatic melanoma.

Eur J Cancer 2018 01 28;88:67-76. Epub 2017 Nov 28.

Skin Cancer Center Hannover, Dept. of Dermatology and Allergy, Hannover Medical School, Carl Neuberg Str. 1, 30625 Hannover, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.10.026DOI Listing
January 2018

Safe Administration of An Anti-PD-1 Antibody to Kidney-transplant Patients: 2 Clinical Cases and Review of the Literature.

J Immunother 2017 Nov/Dec;40(9):341-344

*Department of Dermatology and National Center for Tumor Diseases (NCT) ‡Department of Nephrology, University Hospital Heidelberg, Heidelberg †Department of Dermatology and Allergy, Hannover Medical School, Skin Cancer Center, Hannover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000188DOI Listing
May 2018

Histamine H2 receptor stimulation upregulates T2 chemokine CCL17 production in human M2a macrophages.

J Allergy Clin Immunol 2018 02 18;141(2):782-785.e5. Epub 2017 Jul 18.

Division of Immunodermatology and Allergy Research, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaci.2017.06.023DOI Listing
February 2018

Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator's Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial.

J Clin Oncol 2018 02 3;36(4):383-390. Epub 2017 Jul 3.

James Larkin, Royal Marsden NHS Foundation Trust, London; Paul Lorigan, The Christie National Health Service Foundation Trust, Manchester, United Kingdom; David Minor, California Pacific Medical Center Research Institute; Adil Daud, University of California San Francisco, San Francisco; Bartosz Chmielowski, University of California, Santa Monica, CA; Sandra D'Angelo, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; Jeffrey Weber, Perlmutter Cancer Center at New York University-Langone Medical Center, New York; Nikhil Khushalani, Roswell Park Cancer Institute, Buffalo, NY; Gerald Linette, Washington University, St. Louis, MO; Christopher D. Lao, University of Michigan, Ann Arbor, MI; Kenneth Grossmann, Huntsman Cancer Institute, Salt Lake City, UT; Mario Sznol, Yale Comprehensive Cancer Center, New Haven, CT; Jeffrey Sosman, Northwestern University, Chicago, IL; Dana Walker, George Kong, and Christine Horak, Bristol-Myers Squibb, Princeton, NJ; Bart Neyns, University Hospital, Vrije Universiteit Brussel, Brussels, Belgium; Michael Smylie, Cross Cancer Institute, Edmonton, Alberta; Wilson H. Miller Jr, Jewish General Hospital and Segal Cancer Centre, McGill University, Montreal, Quebc, Canada; Ralf Gutzmer, Medizinische Hochschule Hannover, Hannover; Jessica C. Hassel, Nationale Centrum für Tumorerkrankungen Heidelberg, Heidelberg; Dirk Schadendorf, University Hospital Essen, Essen, Germany; and Christoph Hoeller, Medical University of Vienna, Wien, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.8023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804912PMC
February 2018

Anti-PD-1 antibodies in metastatic uveal melanoma: a treatment option?

Cancer Med 2017 Jul 21;6(7):1581-1586. Epub 2017 Jun 21.

Department of Dermatology and National Center for Tumor Diseases, University Hospital Heidelberg, Im Neuenheimer Feld 440/460, Heidelberg, 69120, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.887DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504332PMC
July 2017

Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions.

Cancer Treat Rev 2017 Jun 18;57:36-49. Epub 2017 May 18.

Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2017.05.003DOI Listing
June 2017

Combined treatment with H1 and H4 receptor antagonists reduces inflammation in a mouse model of atopic dermatitis.

J Dermatol Sci 2017 Aug 21;87(2):130-137. Epub 2017 Apr 21.

University of Veterinary Medicine Hannover, Institute for Pharmacology, Toxicology and Pharmacy, Hannover, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jdermsci.2017.04.004DOI Listing
August 2017

Reinduction of PD1-inhibitor therapy: first experience in eight patients with metastatic melanoma.

Melanoma Res 2017 08;27(4):321-325

aDepartment of Dermatology and Allergy Hannover Medical School, Skin Cancer Center Hannover, Hannover bDepartment of Dermatology, University Hospital Heidelberg, Heidelberg cDepartment of Dermatology, University Hospital Tuebingen, Tuebingen dDepartment of Dermatology, Phlebology and Allergology, Hospital Bremerhaven-Reinkenheide, Bremerhaven, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000341DOI Listing
August 2017

Clinics, prognosis and new therapeutic options in patients with mucosal melanoma: A retrospective analysis of 75 patients.

Medicine (Baltimore) 2017 Jan;96(1):e5753

aDepartment for Dermatology and Allergy, Skin Cancer Center Hannover (HTZH), Hannover Medical School bOffice for Dermatology, Allergy and Venerology, Seelze, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000005753DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228677PMC
January 2017

Characterisation of Prognosis and Invasion of Cutaneous Squamous Cell Carcinoma by Podoplanin and E-Cadherin Expression.

Dermatology 2016 23;232(5):558-565. Epub 2016 Nov 23.

Skin Cancer Center Hannover, Department for Dermatology and Allergy, Hannover Medical School, Hannover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000450920DOI Listing
July 2017

Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG "GERMELATOX survey") versus melanoma recurrence to quantify patients' relative values for adjuvant therapy.

Medicine (Baltimore) 2016 Nov;95(46):e5375

aDepartment of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel bInstitute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg, Hamburg cDepartment of Dermatology, Eberhard-Karls University of Tuebingen, Tuebingen dSkin Cancer Center Hannover, Hannover eUniversity of Hamburg, Hamburg fDepartment of Dermatology, University Hospital Erlangen, Erlangen gTABEA Clinic, Hamburg hDepartment of Dermatology, University Hospital Essen, Essen iDepartment of Dermatology, University of Mainz, Mainz jMSD Sharp & Dohme GmbH, Munich kDepartment of Dermatology, University Hospital (UKSH), Campus Lübeck, Luebeck lSkin Cancer Unit, German Cancer Research Center (DKFZ) mDepartment of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000005375DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120927PMC
November 2016

Genetic variations within the promotor region of the human histamine H4 receptor gene in psoriasis patients.

Pharmacol Res 2016 12 7;114:121-127. Epub 2016 Oct 7.

Division of Immunodermatology and Allergy Research, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.phrs.2016.10.003DOI Listing
December 2016

Stimulation of the histamine 4 receptor upregulates thymic stromal lymphopoietin (TSLP) in human and murine keratinocytes.

Pharmacol Res 2016 11 1;113(Pt A):209-215. Epub 2016 Aug 1.

Division of Immunodermatology and Allergy Research, Department of Dermatology and Allergy, Hannover Medical School, Carl-Neuberg-Straße 1, 30625 Hannover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.phrs.2016.08.001DOI Listing
November 2016

Management of side effects of immune checkpoint blockade by anti-CTLA-4 and anti-PD-1 antibodies in metastatic melanoma.

J Dtsch Dermatol Ges 2016 Jul;14(7):662-81

Hanover Skin Cancer Center, Department of Dermatology, Venereology, and Allergology, Hanover Medical College, Hanover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ddg.13047DOI Listing
July 2016

Nebenwirkungsmanagement bei Immun-Checkpoint-Blockade durch CTLA-4- und PD1-Antikörper beim metastasierten Melanom.

J Dtsch Dermatol Ges 2016 Jul;14(7):662-83

Hauttumorzentrum Hannover, Klinik für Dermatologie, Allergologie und Venerologie, Medizinische Hochschule Hannover.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ddg.13047_gDOI Listing
July 2016

Effects of mammalian target of rapamycin inhibitors on cytokine production and differentiation in keratinocytes.

Exp Dermatol 2016 10;25(10):775-82

Department for Dermatology, Allergology and Venerology, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/exd.13079DOI Listing
October 2016

Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy.

Cancer Treat Rev 2016 Apr 18;45:7-18. Epub 2016 Feb 18.

Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2016.02.003DOI Listing
April 2016

Current diagnosis and treatment of basal cell carcinoma.

J Dtsch Dermatol Ges 2015 Sep;13(9):863-74; quiz 875

Skin Tumor Center Hanover, Department of Dermatology, Allergology, and Venereology, Medical University Hanover, Hanover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ddg.12798DOI Listing
September 2015

[Reduction of relapse in the radiation area by adjuvant lymph-node field radiotherapy in metastatic malignant melanoma patients at high risk of recurrence].

Strahlenther Onkol 2016 Mar;192(3):190-2

Klinik für Strahlentherapie und Spezielle Onkologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00066-015-0936-xDOI Listing
March 2016